Mechanism of substance P-induced activations of human neutrophils.
スポンサーリンク
概要
- 論文の詳細を見る
To determine the mechanism by which substance P (SP) activates human neutrophils, we examined the potency of SP for inducing chemotaxis, lysozyme release, and increase in cytosolic free Ca<SUP>2+</SUP> concentration ( [Ca<SUP>2+</SUP>] i) in human blood neutrohils. We also examined the effects of EGTA and of a formyl-Met-Leu-Phe (FMLP) antagonist on the responses. SP (10<SUP>-6</SUP> to 10<SUP>-4</SUP> M) induced chemotaxis, lysozyme release, and the increase in [Ca<SUP>2+</SUP>] i of the neutrophils dose-dependently. Preincubation with EGTA (10 mM) decreased the SP-induced increase in [Ca<SUP>2+</SUP>] i by 90%, whereas EGTA decreased the FMLP-induced increase in [Ca<SUP>2+</SUP>] i only by 37%, suggesting that the activations of human neutrophils by SP are dependent on the influx of extracellular Ca<SUP>2+</SUP>. An FMLP antagonist, boc-Phe-Leu-Phe-Leu-Phe, inhibited the FMLP-induced chemotaxis and increase in [Ca<SUP>2+</SUP>] i, but it did not inhibit the SP-induced respones.<BR>We suggest that SP induces the activations of human neutrophils by the different mechanism from that of FMLP.
- 日本炎症・再生医学会の論文
日本炎症・再生医学会 | 論文
- 新規キノリノン誘導体TA-270の炎症性気道疾患に対する効果
- Salazosulphapyridine, Predonizolone の好中球機能に及ぼす影響と Sodium ferrous citrate との併用効果についての検討
- Sodium ferrous citrate の好中球機能に及ぼす影響
- Mesalazine(Pentasa) の好中球機能に及ぼす影響と Sodium ferrous citrate(SFC) との併用効果についての検討
- 非ウイルスベクターによる細胞標的法の開発